A Feasible Pathway for Open Access to Human Embryonic Stem Cell Patents —With China's Open License for Patent as the Entry Point

Biotechnology Law Report,Volume 43, Issue 1, Page 33-41, February 2024.

Source: Biotechnology Law Report - February 14, 2024 Category: Medical Law Authors: JIAJV CHEN Source Type: research